HKSE - Delayed Quote HKD
CONSUN PHARMA (1681.HK)
9.490
-0.080
(-0.84%)
At close: 4:08:18 PM GMT+8
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 411.64M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| An (Meng) Chief Executive Officer | -- | Direct | -- | Apr 23, 2025 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.76 per share. | Direct | 70,113 | Sep 17, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.74 per share. | Direct | 259,595 | Sep 16, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.74 per share. | Direct | 219,391 | Sep 13, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.73 per share. | Direct | 621,969 | Sep 12, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.72 per share. | Direct | 738,387 | Sep 11, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.71 per share. | Direct | 370,007 | Sep 10, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.68 per share. | Direct | 196,475 | Sep 5, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.72 per share. | Direct | 595,027 | Sep 4, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.72 per share. | Direct | 724,462 | Sep 3, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.72 per share. | Direct | 687,230 | Sep 2, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.72 per share. | Direct | 64,863 | Aug 29, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.72 per share. | Direct | 244,052 | Aug 28, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.76 per share. | Direct | 981,630 | Jul 5, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.73 per share. | Direct | 36,685 | Jul 4, 2024 |
| An (Meng) Chief Executive Officer | Acquisition at price 0.72 per share. | Direct | 88,350 | Jul 3, 2024 |
| Zhu (Quan) Director (Executive) | Conversion at price 0.51 per share. | Direct | 661,105 | Jun 6, 2024 |
| Zhu (Quan) Director (Executive) | Sale at price 0.84 per share. | Direct | 1,081,668 | Jun 6, 2024 |
| Li (Qian) Chief Executive Officer | Other at price 0.47 per share. | Direct | 284,739 | Nov 17, 2021 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.42 per share. | Direct | 546,650 | Mar 24, 2020 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.51 per share. | Direct | 72,036 | Jan 17, 2020 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.50 per share. | Direct | 111,611 | Jan 16, 2020 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.50 per share. | Direct | 75,270 | Jan 15, 2020 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.50 per share. | Direct | 50,139 | Jan 14, 2020 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.49 per share. | Direct | 49,410 | Jan 13, 2020 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.49 per share. | Direct | 38,103 | Jan 10, 2020 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.54 per share. | Direct | 11,987 | Oct 4, 2019 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.54 per share. | Direct | 15,212 | Oct 3, 2019 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.54 per share. | Direct | 62,408 | Oct 2, 2019 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.55 per share. | Direct | 37,223 | Sep 30, 2019 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.55 per share. | Direct | 63,637 | Sep 26, 2019 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.55 per share. | Direct | 4,388 | Sep 5, 2019 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.56 per share. | Direct | 63,940 | Aug 26, 2019 |
| An (Yubao) Chairman of the Board | Acquisition at price 0.90 per share. | Direct | 45,020 | Jun 28, 2018 |
| An (Yubao) Chairman of the Board | Acquisition at price 0.95 per share. | Direct | 1,546,024 | Jun 27, 2018 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.95 per share. | Direct | 126,070 | Jun 27, 2018 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.98 per share. | Direct | 55,842 | Jun 8, 2018 |
| An (Yubao) Chairman of the Board | Acquisition at price 0.98 per share. | Direct | 167,195 | Jun 8, 2018 |
| An (Yubao) Chairman of the Board | Acquisition at price 0.97 per share. | Direct | 29,172 | Jun 7, 2018 |
| Cheng (Xinxin) Director (Independent) | Acquisition at price 0.93 per share. | Direct | 234,784 | Oct 31, 2017 |
| An (Yubao) Chairman of the Board | Acquisition at price 0.83 per share. | Direct | 7,476 | Oct 19, 2017 |
| Li (Qian) Chief Executive Officer | Acquisition at price 0.84 per share. | Direct | 84,280 | Oct 19, 2017 |
| Li (Qian) Chief Executive Officer | Other at price 0.77 per share. | Direct | 75,087 | Jul 4, 2017 |
| Li (Qian) Chief Executive Officer | Other at price 0.78 per share. | Direct | 268,285 | Jul 3, 2017 |
| Cheng (Xinxin) Director (Independent) | Other at price 0.76 per share. | Direct | 284,972 | Jun 29, 2017 |
| An (Yubao) Chairman of the Board | Other at price 0.73 per share. | Direct | 17,503 | Jun 23, 2017 |
| An (Yubao) Chairman of the Board | Other at price 0.73 per share. | Direct | 326,655 | Jun 22, 2017 |
| Li (Qian) Chief Executive Officer | Other at price 0.72 per share. | Direct | 11,508 | Jun 22, 2017 |
| Li (Qian) Chief Executive Officer | Other at price 0.72 per share. | Direct | 90,387 | Jun 21, 2017 |
| Cheng (Xinxin) Director (Independent) | Other at price 0.70 per share. | Direct | 105,390 | Jun 13, 2017 |
Related Tickers
3933.HK The United Laboratories International Holdings Limited
13.200
+2.01%
1513.HK LIVZON PHARMA
26.550
-0.56%
3692.HK Hansoh Pharmaceutical Group Company Limited
23.450
+3.76%
6896.HK Golden Throat Holdings Group Company Limited
5.430
+6.26%
BXP.L Beximco Pharmaceuticals Limited
34.64
-3.78%
2005.HK SSY Group Limited
2.890
0.00%
0512.HK GRAND PHARMA
8.430
+2.93%
2877.HK China Shineway Pharmaceutical Group Limited
7.150
+0.85%
2633.HK Jacobson Pharma Corporation Limited
1.210
0.00%
2161.HK JBM (Healthcare) Limited
2.120
0.00%